Form 4: ACM Research Officer Executes Pre-Planned Stock Option Exercise and Share Sale

Lisa Feng, Chief Financial Officer of ACM Research (Shanghai), Inc., exercised stock options and subsequently sold 15,000 shares of ACM Research Class A Common Stock on July 7, 2025, pursuant to a Rule 10b5-1 trading plan.

Summary

• Lisa Feng, an officer of ACM Research, Inc. (ACMR) and specifically the Chief Financial Officer of its subsidiary ACM Research (Shanghai), Inc., completed two transactions on July 7, 2025.
• She exercised a previously issued stock option to acquire 15,000 shares of Class A Common Stock at an exercise price of $5.6 per share.
• Immediately following the exercise, she sold all 15,000 of these newly acquired Class A Common Stock shares at a price of $28 per share.
• The sale was conducted under a pre-arranged Rule 10b5-1 trading plan, which was adopted by Lisa Feng on March 12, 2025.
• After these reported transactions, Lisa Feng beneficially owns 50,001 shares of Class A Common Stock.
• The stock option exercised was fully vested and exercisable, with an expiration date of April 22, 2029.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. While an insider sale might be viewed with caution, its execution under a pre-planned 10b5-1 program mitigates negative interpretations. The significant profit realized from the option exercise is a positive for the individual officer.

Positives

• The transaction was executed under a Rule 10b5-1 trading plan, indicating a pre-scheduled and non-discretionary sale, which often mitigates concerns about opportunistic insider selling.
• The significant difference between the exercise price ($5.6) and the sale price ($28) demonstrates a substantial profit for the officer on the exercised shares, reflecting value creation from the company's stock performance.

Negatives

• An insider selling shares, even under a pre-arranged plan, reduces their direct equity stake in the company, which can sometimes be perceived neutrally to slightly negatively by some market participants.

Future Outlook

The document does not provide any forward-looking statements or guidance regarding the company's future performance, strategic direction, or financial outlook, as it is solely a report on an insider's equity transactions.

Management Comments

• On July 7, 2025, the reporting person exercised a previously issued stock option to purchase 15,000 shares of Class A Common Stock of the Issuer.
• The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 12, 2025.

Industry Context

This Form 4 filing details an individual insider transaction and does not offer broader industry context. Insider transactions, particularly those involving option exercises and subsequent sales under Rule 10b5-1 plans, are a common occurrence across various industries, including the technology and semiconductor equipment sectors where ACM Research operates, as part of executive compensation and personal financial management.

Comparison to Industry Standards

• This document reports a routine insider transaction (option exercise and sale) and does not contain information that allows for a direct comparison to industry-specific financial benchmarks or project results.
• Such transactions are a standard component of executive compensation and personal financial planning across a wide range of publicly traded companies, including those comparable to ACM Research in the semiconductor equipment sector.

Stakeholder Impact

• Shareholders: The sale of shares by an officer slightly reduces their direct ownership stake, but the pre-planned nature of the transaction under a 10b5-1 plan suggests it is a routine personal financial management event rather than a signal of negative company outlook. The profit realized by the officer from the option exercise could be seen as a positive indicator of value creation.
• Employees: No direct impact on employees is indicated by this filing.
• Customers: No direct impact on customers is indicated by this filing.
• Suppliers: No direct impact on suppliers is indicated by this filing.
• Creditors: No direct impact on creditors is indicated by this filing.

Next Steps

• No specific future actions, events, or milestones for the company are mentioned in this insider transaction report, as its purpose is to disclose past equity transactions.

Key Dates

Recommendation

Keywords

ACM Research, ACMR, Form 4, Insider Trading, Stock Option Exercise, Share Sale, 10b5-1 Plan, Lisa Feng, Officer Transaction, Equity Compensation